Overview
Product nameHIV1 + HIV2 envelope antigen proteinSee all HIV1 + HIV2 envelope antigen proteins and peptides ...
Protein descriptionRecombinant HIV1 envelope conjugated to HIV2 envelope peptide
Expression hostE. coli
Properties
Purification notesPurified
Biological activityDetects all HIV1,2 infected individuals responding to HIV1,2 envelope proteins.
FormLiquid
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferPreservative: 0.01% Sodium Azide
Constituents: 50% Glycerol, 1.5M Urea, 25mM Tris HCl, 1mM EDTA
Concentration information loading...
Research Areas
Applications
Our Abpromise guarantee covers the use of
ab48966
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|
Application
|
Notes |
| ELISA |
ELISA: Use at an assay dependent dilution. |
| WB |
WB: Use at an assay dependent dilution. |
Protein info
-
Alternative names
Envelope glycoprotein gp160Glycoprotein 120Glycoprotein 41
see all
RelevanceInhibitors targeting HIV1 viral envelope proteins are used as antiretroviral drugs. The surface protein gp120 attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CXCR4 and/or CCR5. The transmembrane protein gp41 acts as a class I viral fusion protein.
References for HIV1 + HIV2 envelope antigen protein (ab48966)
ab48966
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
